Futura Medical PLC Block Listing Update (2178Q)
November 25 2016 - 9:05AM
UK Regulatory
TIDMFUM
RNS Number : 2178Q
Futura Medical PLC
25 November 2016
For immediate release 25 November 2016
Futura Medical plc
("Futura" or "the Company")
Block Listing Update
Futura Medical plc (AIM: FUM), the innovative healthcare company
focused on advanced transdermal technology makes the following
update on its block listing, pursuant to AIM Rule 29 and Schedule 6
of the AIM Rules for Companies. All figures relate to options over
ordinary shares of 0.2 pence each.
The table below provides further detail.
Name of company: Futura Medical plc
Name of scheme: Unapproved Share Option Scheme ("USOS")
EMI Share Option Scheme ("EMI")
Period of return: From: 20 May 2016
To: 24 November 2016
Number and class of securities not issued under
the scheme(s) USOS: 1,440,600
EMI: 1,344,141
Total: 2,784,741
Number of securities issued under the scheme(s) USOS: Nil
during the period
Number of securities lapsed under the scheme(s)
during the period (EMI adjustment to May return)
EMI: Nil
USOS: (284,279)
EMI: 20,000
Balance under the scheme(s) of securities not
yet issued at the end of the period USOS: 1,156,321
EMI: 1,364,141
Total: 2,470,462
Number and class of securities originally USOS: 814,424 on 25 May 2011 and 1,202,280 on 8
admitted and the date of admission October 2013
USOS Total: 2,016,704
EMI: 1,520,576 on 25 May 2011 and 1,467,720 on 8
October 2013
EMI Total: 2,988,296
Total: 5,005,000
Name of contact: Derek Martin, Chief Financial Officer
Telephone number of contact: +44 (0) 1483 685 670
For further information please contact:
Futura Medical plc
James Barder, Chief Executive Tel: +44 (0) 1483
685 670
Email to: james.barder@futuramedical.com www.futuramedical.com
N+1 Singer (Nominated Adviser
and Broker)
Aubrey Powell / Liz Yong Tel:+44 (0) 20 7496
Corporate Finance 3000
For media enquiries please
contact:
Buchanan
Mark Court / Sophie Cowles Tel: +44 (0) 20 7466
/ Stephanie Watson 5000
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops
innovative products for consumer healthcare. The Company is
developing a portfolio of products and its strategy is to license
their manufacture and distribution to major pharmaceutical and
healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on
the AIM market of the London Stock Exchange.
www.futuramedical.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRPGGCUGUPQGAA
(END) Dow Jones Newswires
November 25, 2016 10:05 ET (15:05 GMT)
Futura Medical (LSE:FUM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Futura Medical (LSE:FUM)
Historical Stock Chart
From Apr 2023 to Apr 2024